Stock listing
NASDAQ:IMNM Immunome, Inc. Stock
Home listing (NASDAQ) of Immunome, Inc.
Follow Immunome, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IMNM
$18.21 USD -0.08 (-0.4%)
Close on Oct 30, 2026
- Day range
- $17.82 – $18.98 USDOct 30, 2026
- Volume
- 1.27M sharesOct 30, 2026
- Market cap
- $2.15B USDAt the close on Oct 30, 2026 · price × 118.0M shares outstanding
- 52-week range
- $14.64 – $30.06 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $29.26M USDMedian day 1.09M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IMNM · Home | $18.21 USD | -0.08 (-0.4%) | 1,270,371 | $18.25 | $18.98 | $17.82 | $18.29 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IMNM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $18.21 | -0.08 | -0.4% | $18.25 | $18.98 | $17.82 | 1,270,371 | |
| $18.29 | -0.47 | -2.5% | $18.88 | $19.30 | $18.11 | 877,800 | |
| $18.76 | -0.01 | -0.1% | $18.50 | $18.91 | $18.25 | 952,015 | |
| $18.77 | +0.88 | +4.9% | $17.95 | $19.00 | $17.50 | 1,225,654 | |
| $17.89 | -0.10 | -0.6% | $17.99 | $18.35 | $17.70 | 910,525 | |
| $17.99 | -0.27 | -1.5% | $18.13 | $18.25 | $17.65 | 1,378,899 | |
| $18.26 | +0.26 | +1.4% | $17.78 | $18.30 | $17.59 | 1,761,590 | |
| $18.00 | +0.08 | +0.4% | $17.99 | $18.44 | $17.85 | 1,545,126 | |
| $17.92 | +1.15 | +6.9% | $16.74 | $18.27 | $16.55 | 2,029,591 | |
| $16.77 | +0.30 | +1.8% | $16.60 | $16.92 | $16.44 | 1,139,956 | |
| $16.47 | -0.93 | -5.3% | $17.40 | $17.40 | $16.41 | 1,297,600 | |
| $17.40 | +0.20 | +1.2% | $17.31 | $17.61 | $17.08 | 1,621,100 | |
| $17.20 | -0.38 | -2.2% | $17.35 | $18.05 | $17.13 | 1,154,900 | |
| $17.58 | -1.57 | -8.2% | $19.06 | $19.16 | $17.43 | 2,198,600 | |
| $19.15 | -0.40 | -2.0% | $19.42 | $19.73 | $19.08 | 835,700 | |
| $19.55 | +0.24 | +1.2% | $19.05 | $19.72 | $18.88 | 998,000 | |
| $19.31 | +0.215 | +1.1% | $18.88 | $19.35 | $18.52 | 2,131,000 | |
| $19.10 | -0.215 | -1.1% | $18.94 | $19.56 | $18.94 | 1,161,000 | |
| $19.31 | -1.86 | -8.8% | $21.35 | $21.43 | $18.92 | 2,310,800 | |
| $21.17 | +0.27 | +1.3% | $20.79 | $21.48 | $20.67 | 1,216,200 | |
| $20.90 | +0.01 | 0.0% | $21.33 | $21.46 | $20.82 | 1,171,600 | |
| $20.89 | -0.62 | -2.9% | $21.17 | $21.49 | $20.71 | 1,096,800 | |
| $21.51 | -0.38 | -1.7% | $22.15 | $22.56 | $21.51 | 1,306,000 | |
| $21.89 | +0.21 | +1.0% | $21.64 | $22.01 | $21.36 | 917,000 | |
| $21.68 | +0.27 | +1.3% | $21.24 | $21.81 | $20.85 | 945,200 | |
| $21.41 | -0.93 | -4.2% | $22.43 | $22.65 | $21.15 | 2,421,600 | |
| $22.34 | -1.90 | -7.8% | $24.24 | $24.34 | $22.21 | 2,697,400 | |
| $24.24 | -1.51 | -5.9% | $25.88 | $25.94 | $24.04 | 2,270,600 | |
| $25.75 | +0.68 | +2.7% | $25.17 | $25.81 | $25.09 | 1,064,500 | |
| $25.07 | +1.10 | +4.6% | $24.63 | $25.26 | $24.19 | 1,180,500 | |
| $23.97 | +0.04 | +0.2% | $24.01 | $24.24 | $23.36 | 3,962,500 | |
| $23.93 | +0.47 | +2.0% | $24.10 | $24.64 | $23.77 | 890,800 | |
| $23.46 | -0.49 | -2.0% | $24.29 | $24.75 | $23.36 | 1,317,800 | |
| $23.95 | -0.60 | -2.4% | $24.44 | $24.48 | $23.55 | 1,332,000 | |
| $24.55 | -0.12 | -0.5% | $24.65 | $25.26 | $24.40 | 744,600 | |
| $24.67 | -0.30 | -1.2% | $25.32 | $25.73 | $24.60 | 692,600 | |
| $24.97 | -1.15 | -4.4% | $25.69 | $26.08 | $24.91 | 729,900 | |
| $26.12 | -0.69 | -2.6% | $26.43 | $26.99 | $26.10 | 784,100 | |
| $26.81 | +0.05 | +0.2% | $26.15 | $27.25 | $25.91 | 828,600 | |
| $26.76 | -0.40 | -1.5% | $26.68 | $27.14 | $26.66 | 562,300 | |
| $27.16 | -0.17 | -0.6% | $27.60 | $28.27 | $26.67 | 796,100 | |
| $27.33 | +0.265 | +1.0% | $27.56 | $28.49 | $26.81 | 811,100 | |
| $27.07 | -0.345 | -1.3% | $27.23 | $27.31 | $26.64 | 700,200 | |
| $27.41 | -0.16 | -0.6% | $27.48 | $27.63 | $27.00 | 1,050,700 | |
| $27.57 | -1.30 | -4.5% | $28.45 | $28.77 | $27.40 | 783,500 | |
| $28.87 | +0.12 | +0.4% | $28.57 | $29.11 | $28.35 | 1,055,500 | |
| $28.75 | -0.635 | -2.2% | $29.34 | $29.39 | $28.62 | 558,800 | |
| $29.39 | +1.375 | +4.9% | $27.88 | $29.72 | $27.88 | 1,928,300 | |
| $28.01 | -0.51 | -1.8% | $28.48 | $28.85 | $27.64 | 1,355,400 | |
| $28.52 | +0.44 | +1.6% | $28.46 | $29.30 | $28.13 | 846,500 | |
| $28.08 | -1.745 | -5.9% | $29.13 | $29.15 | $27.89 | 1,025,500 | |
| $29.83 | +2.265 | +8.2% | $27.85 | $30.06 | $27.63 | 2,984,600 | |
| $27.56 | +0.16 | +0.6% | $27.10 | $27.69 | $26.76 | 965,300 | |
| $27.40 | +0.20 | +0.7% | $26.89 | $27.80 | $26.69 | 1,186,900 | |
| $27.20 | +0.78 | +3.0% | $26.38 | $27.30 | $25.59 | 760,800 | |
| $26.42 | -1.57 | -5.6% | $28.60 | $28.62 | $26.33 | 946,900 | |
| $27.99 | +1.74 | +6.6% | $25.23 | $28.04 | $25.23 | 1,561,300 | |
| $26.25 | +0.56 | +2.2% | $25.81 | $26.47 | $25.42 | 886,900 | |
| $25.69 | +0.66 | +2.6% | $24.99 | $26.15 | $24.49 | 1,232,600 | |
| $25.03 | -0.79 | -3.1% | $26.19 | $26.25 | $24.80 | 881,100 | |
| $25.82 | +0.30 | +1.2% | $25.44 | $26.42 | $25.32 | 860,100 | |
| $25.52 | +0.46 | +1.8% | $25.30 | $25.84 | $24.89 | 1,092,400 | |
| $25.06 | +2.05 | +8.9% | $23.36 | $25.37 | $23.09 | 1,802,100 | |
| $23.01 | +0.25 | +1.1% | $22.67 | $23.07 | $22.12 | 1,771,200 | |
| $22.76 | -0.32 | -1.4% | $23.70 | $23.70 | $22.48 | 658,100 | |
| $23.08 | -0.03 | -0.1% | $23.00 | $23.23 | $22.75 | 595,400 |
- Ticker
- NASDAQ:IMNM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 33 slides
Latest news
Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
Oct 30, 2026
Closed $18.21 (-0.4%) on Oct 30, 2026
Immunome Presents Additional Clinical Data for Varegacestat in Desmoid Tumors at ESMO 2026
Oct 26, 2026
Closed $17.89 (-0.6%) on Oct 26, 2026
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 6, 2026
Closed $19.10 (-1.1%) on Oct 7, 2026
Immunome Announces IND Clearance for IM-1340, a Potential First-in-Class Antibody-Drug Conjugate for the Treatment of Solid Tumors
Sep 30, 2026
Closed $21.51 (-1.7%) on Sep 30, 2026
Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 2, 2026
Closed $27.33 (+1.0%) on Sep 2, 2026
Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026
Closed $27.99 (+6.6%) on Aug 12, 2026
Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-3050, an FAP-Targeted Radioligand Therapy, in Patients with FAP-Expressing Advanced Solid Tumors
Jul 20, 2026
Closed $22.16 (-0.7%) on Jul 20, 2026
Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors
Jul 8, 2026
Closed $24.01 (-1.6%) on Jul 8, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 33 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 32 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 33 slides · September 2026
2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Conference · 14 slides · Jun 2, 2026
Immunome, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 129 in all · newest Oct 30, 2026 · oldest 2020
- Decks
- 35 decks · latest October 2026
Where Immunome, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IMNM · Home listing · This page | NASDAQ | United States | USD |
| BOATS:IMNM | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Immunome, Inc.